INC Research, still completing its $232 million acquisition of clinical research organization Kendle International Inc. (NSDQ:KNDL), bought yet another CRO to add to its global footprint.

Raleigh, N. C.-based INC Research acquired Australian CRO Trident Clinical Research in an aggressive move that gets INC into a fast-growing market for early phase clinical studies.